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Abstract
Background: Ghrelin is a 28-amino acid octanolyated peptide, synthesised primarily in the stomach. It stimulates 
growth hormone release, food intake and exhibits many other diverse effects. Our group have previously determined 
that ghrelin inhibited human contractility in vitro. The aim of this study therefore, was to investigate the expression of 
ghrelin, its receptor, the growth hormone secretagogue receptor type 1 (GHS-R1), ghrelin O-acyltransferase (GOAT) 
which catalyses ghrelin octanoylation, prohormone convertase 1/3 (PC1/3) responsible for pro-ghrelin processing, in 
human myometrium, during pregnancy prior to labour, during labour and in the non-pregnant state. Modulation of 
ghrelin and ghrelin receptor expression in cultured myometrial cells was also investigated.
Methods: mRNA and protein were isolated from human myometrium and the myometrial smooth muscle cell line 
hTERT-HM; and real-time fluorescence RT-PCR, western blotting and fluorescence microscopy performed. The effects of 
β-Estradiol and bacterial lipopolysaccharide (LPS) on hTERT-HM gene expression were evaluated by western blotting.
Results: We have reported for the first time the expression and processing of ghrelin, GHS-R1, GOAT and PC1/3 
expression in human myometrium, and also the down-regulation of ghrelin mRNA and protein expression during 
labour. Furthermore, GHS-R1 protein expression significantly decreased at labour. Myometrial GOAT expression 
significantly increased during term non-labouring pregnancy in comparison to both non-pregnant and labouring 
myometrium. Mature PC1/3 protein expression was significantly decreased at term pregnancy and labour in 
comparison to non-pregnant myometrium. Ghrelin, GHS-R1, GOAT and PC1/3 mRNA and protein expression was also 
detected in the hTERT-HM cells. Ghrelin protein expression decreased upon LPS treatment in these cells while β-
Estradiol treatment increased GHS-R1 expression.
Conclusions: Ghrelin processing occurred in the human myometrium at term pregnancy and in the non-pregnant 
state. GOAT expression which increased during term non-labouring pregnancy demonstrating a similar expression 
pattern to prepro-ghrelin and GHS-R1, decreased at labour, signifying possible myometrial ghrelin acylation. Moreover, 
the presence of PC1/3 may contribute to pro-ghrelin processing. These results along with the previous in vitro data 
suggest that myometrially-produced and processed ghrelin plays a significant autocrine or paracrine role in the 
maintenance of relaxation in this tissue during pregnancy. Furthermore, the significant uterine modulators LPS and β-
Estradiol are involved in the regulation of ghrelin and ghrelin receptor expression respectively, in the human 
myometrium.
Background
Ghrelin is an acylated 28-amino acid hormone [1] synthe-
sised primarily in the stomach, it is also found in a wide
range of other tissues including the hypothalamus, pla-
centa, ovary, testis and endometrium [2,3]. Ghrelin has
an  N-octanoyl group covalently linked to the hydroxyl
group of its serine-3 residue, this modification being nec-
essary for ghrelin to bind to its receptor, the growth hor-
mone secretagogue receptor (GHS-R1) [4]. No other
naturally occurring peptide has been identified to have
this post-translational acyl group modification [5]. It is
through the mediation of the seven transmembrane G-
protein coupled receptor GHS-R1, coupled to the Gq sub-
unit that ghrelin elicits growth hormone release, regu-
lates appetite and energy metabolism and performs many
functions in other tissues and organs, such as the repro-
ductive system. In obese non-pregnant adults ghrelin lev-
els are reduced but are increased in subjects of low body
mass index [6]. GHS-R1 is primarily expressed in the
pituitary and the hypothalamus but is also widely
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expressed in many tissues including the stomach, testis,
ovaries and endometrium [3,7]. The enzyme that cataly-
ses the octanoylation of ghrelin in the endoplasmic retic-
ulum, is ghrelin O-acyltransferase (GOAT) [8,9]. GOAT
or mBOAT4 is a member of the family of membrane-
bound O-acyltransferases. Des-acyl or unacylated ghrelin
is the dominant form of ghrelin in the plasma, it cannot
bind the GHS-R1 receptor but it has been suggested it
plays alternative roles in a GHS-R1 independent pathway
[5,10].
The prepro-ghrelin protein is 117-amino acids in
length: the signal peptide is cleaved to form the 94-amino
acid pro-ghrelin peptide. A pro-hormone convertase 1/3
(PC1/3) is the only enzyme known to be responsible for
the conversion of pro-ghrelin to ghrelin in vivo [11], it
cleaves the 94-amino acid human ghrelin precursor into
the 28-amino acid mature ghrelin, through proteolytic
dibasic cleavage at the LQPR/ALAG site [12]. PC1/3 is
also capable of processing other hormones such as oxyto-
cin [13], in dense core granules of the regulated secretory
pathway [14].
In human pregnancy, total serum ghrelin levels peak
around mid-gestation and fall to their lowest levels in the
third trimester, and increase again postpartum [15,16].
Acylated ghrelin levels were significantly increased in the
2nd, and decreased in the 3rd trimester compared to non-
pregnant samples and samples taken during 1st trimester
of pregnancy [17]. Moreover, acylated ghrelin markedly
decreased during pregnancy compared to the postpartum
period [18]. A previous report from our group high-
lighted that ghrelin had significant inhibitory effects on in
vitro myometrial contractility [19].
Our aim therefore was to determine if ghrelin was
expressed in the myometrium, and if so, investigate its
regulation in this tissue during pregnancy. Firstly, we
investigated ghrelin expression in the human myome-
trium during pregnancy, at term in labour (PL), term not
in labour (PNL) and in the non-pregnant (NP) state. Sec-
ondly, the myometrial expression of GHS-R1, GOAT and
PC1/3 was examined. Thirdly, we studied the effects of
two compounds that regulate myometrial function, β-
Estradiol and LPS, on ghrelin and GHS-R1 expression in
a human myometrial smooth muscle cell line, hTERT-
HM [20].
Methods
Tissue collection
Biopsies of human myometrial tissue during pregnancy
were obtained at elective (pregnant not in labour , PNL,
i.e. prior to labour) and intrapartum (pregnant in labour,
PL) caesarean section operations. The biopsies were
excised from the upper lip of the lower uterine segment
incision in the midline, i.e. the upper portion of the lower
uterine segment. Women who had received prostaglan-
dins or oxytocin for either induction or augmentation of
labour were excluded from the study. Biopsies of human
non-pregnant myometrial tissue (non-pregnant, NP)
were obtained from pre-menopausal hysterectomy speci-
mens, and women receiving therapy with progestagens,
luteinising hormone-releasing hormone analogues, or
steroid based medications were excluded from the study.
Women with gynaecologic malignancy were also
excluded from the study. Myometrial samples were care-
fully dissected to minimise decidual inclusion. Ethical
Committee approval for the tissue collection procedure
was obtained from the Research Ethics Committee Uni-
versity College Hospital, Galway and recruitment was by
written informed consent. Immediately upon collection,
tissue was snap-frozen in liquid nitrogen, and stored at -
80°C.
Tissue samples for real-time fluorescence RT-PCR
PNL (n = 3), PL (n = 3) and NP (n = 3) samples were
obtained for real time RT-PCR. The reasons for elective
caesarean section included previous caesarean section (n
= 2) and placenta praevia (n = 1). The reasons for emer-
gency caesarean section were face presentation (n = 1),
appendectomy (n = 1) and previous classical caesarean
section (n  = 1). The patient demographic data for the
PNL and PL samples is summarised in Table 1. The rea-
sons for hysterectomy were prolapse (n = 1), fibroids (n =
1) and menorrhagia (n = 1), the average age of the hyster-
ectomy samples was 42 (range 41-43).
Tissue samples for protein expression
PNL (n = 5), PL (n = 6) and NP (n = 8) samples were
obtained for western blotting. The reasons for hysterec-
tomy were menorrhagia (n  = 5), prolapse (n  = 2) and
fibroids (n = 1), the average age was 44.5 (range 33-54).
The reasons for elective caesarean section included previ-
ous caesarean section(s) (n = 4) and poor obstetric his-
tory (n = 1). The reasons for emergency caesarean section
were failure to progress/advance (n = 3), face presenta-
tion (n = 1), non-reassuring foetal testing (n = 2). The
patient demographic data for the PNL and PL samples is
presented in Table 2.
Chemicals
Human ghrelin (octanoylated), leptin, LPS, oxytocin,
water soluble β-Estradiol and progesterone were pur-
chased from Sigma (Dublin, Ireland).
Cell culture
Myometrial human telomerase reverse transcriptase
(hTERT-HM) cells kindly provided by Dr. Jennifer C.
Condon [20] were cultured in DMEM-F-12/10% FBS
(Invitrogen, Carlsbad, CA, USA). Prior to treatment for
western blotting, cells were pre-conditioned overnight in
2-10% charcoal stripped FBS (Biosera, East Sussex, UK)O'Brien et al. Reproductive Biology and Endocrinology 2010, 8:55
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and phenol red free DMEM-F12 (Invitrogen, USA) and β-
estradiol and LPS experiments performed in serum-free
phenol red-free medium for 16 hours.
RNA extraction and reverse transcription
Total RNA was isolated from tissue using TRIzol reagent
(Life Technologies Ltd., UK) [21] and cells using the
RNeasy mini RNA isolation kit (Qiagen, Crawley, West
Sussex, UK). RNA (1 μg- DNase I treated) was reverse
transcribed for use as a template for Polymerase Chain
Reaction (PCR). Samples in which no reverse tran-
scriptase was added were included to confirm that no
genomic DNA contamination was present.
Real time fluorescence PCR
Real time fluorescence PCR was performed using the
Applied Biosystems StepOne Plus™ Real Time PCR Sys-
tem Relative Standard Curve method (ABI, Foster City,
CA, USA) [22]. The sequence of oligonucleotide primers
(MWG, Ebersberg, Germany) for real time PCR were:
GHRL (Ghrelin)
5'-TGAGCCCTGAACACCAGAGAG-3'
5'-AAAGCCAGATGAGCGCTTCTA-3' [23]
GHSR
5'-AGCGCTACTTCGCCATC-3'
5'-CCGATGAGACTGTAGAG-3' [24]
GHSRa and b
R1F 5'-TCGTGGGTGCCTCGCT-3'
R1aR 5'- CACCACTACAGCCAGCATTTC-3'
R1bR 5'- GCTGAGACCCACCCAGCA-3' [25]
MBOAT4
5'- CATCTGGACCCTGGAAA-3'
5'-CGAAACCAAACACCTGTC-3' XM_001717299.1
PCSK1 (PC1/3)
5'-TGTTCACACATGGGGAG-3'
5'-ACGAGGCTGCTTCATATG-3' [26]
ACTB
5'-GGGCATGGGTCAGAAGGATT-3'
5'-AGTTGGTGACGATGCCGTG-3' (Accession
M10277)
Each reaction was performed in triplicate. 2-tailed
unpaired student t-tests were performed using Graphpad
Prism 5 software (GraphPad Software, Inc., USA). P val-
ues < 0.05 were considered to be statistically significant.
Protein isolation-tissue
Human myometrial tissue was homogenised and pre-
pared as described previously [27].
Table 1: Real time RT-PCR patient demographic data
Pregnancy State NL (n = 3) L (n = 3)
Mean Age at Delivery (years) +/- SEM 32.7 ± 1.8 33.7 ± 3.7
Range 30-36 29-41
Parity 0: 1 woman
1: 2 women
≥ 2: 0 women
0: 1 woman
1: 1 woman
≥ 2: 1 woman
Mean Gestation Length (weeks) +/- SEM 38.7 ± 0.33 38.1 ± 1.1
Range 38-39 37-40.3
Mean Baby Birth-weight (kg) +/- SEM 3.45 ± 0.06 3.7 ± 0.17
Range 3.0-3.59 3.32-4.48
Table 2: Western blot patient demographic data
Pregnancy State NL (n = 5) L (n = 6)
Mean Age at Delivery (years) +/- SEM 28.7 ± 1.9 35.2 ± 1.9
Range 25-33 28-39
Parity 0: 0 women
1: 2 women
≥ 2: 3 women
0: 2 women
1: 4 women
≥ 2: 0 women
Mean Gestation Length (weeks) +/- SEM 38.2 ± 0.14 40.4 ± 0.3
Range 38-38.7 39.6-41
Mean Baby Birth-weight (kg) +/- SEM 3.3 ± 0.1 3.85 ± 0.2
Range 3.0-3.59 3.32-4.48O'Brien et al. Reproductive Biology and Endocrinology 2010, 8:55
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Protein isolation-cells
Cell pellets after trypsinisation were washed in 1×PBS,
centrifuged and re-suspended in ice-cold lysis buffer [28].
Western blot analysis
Proteins were resolved by SDS (w/v) polyacrylamide gel
electrophoresis gels (BioRad, Hercules, CA, USA) as pre-
viously described [29]. Membranes were blocked and
incubated overnight at 4°C with 1/50-1/100 dilution of
anti-human ghrelin rabbit polyclonal primary antibody
(sc-50297), 1/100 dilution of ghrelin goat polyclonal (sc
10368), 1/100-1/200 GHS-R1 rabbit polyclonal (sc20748)
(Santa Cruz Biotechnology Inc., Rockford, IL, USA), 1/
500 GOAT rabbit (H-032-12) (Phoenix Pharmaceuticals
Inc. Beach Road, Burlinghame, CA, USA), 1/500 PC1/3
mouse monoclonal (ab55543) (Abcam plc, Milton Road,
Cambridge, UK) or 10,000 dilution of β-actin (ACTB)
mouse monoclonal AC-15 (Sigma-Aldrich, Ireland) anti-
bodies. Blots were washed and incubated in either 1:4,000
dilution of rabbit anti-goat (DakoCytomation Ltd, UK),
1:1000 goat anti-rabbit or 1:1000 dilution goat anti-
mouse horseradish peroxidase-conjugated secondary
antibodies (Pierce Technology, USA), the bound second-
ary antibody was detected as previously described [29].
Statistical analysis of the densitometric data for each pro-
tein band compared to β-Actin (one way ANOVA with
Tukey's post hoc analysis or 2-tailed unpaired student t-
tests) and graph construction were performed using
GraphPad Prism version 4 (GraphPad Software Inc.,
USA).
Immunofluorescence microscopy
Cells were prepared as described previously and incu-
bated with primary antibodies to ghrelin, GHS-R1,
GOAT or PC1/3 [29].
Results
Real time fluorescence RT-PCR-Tissue
Ghrelin
There was a significant decrease in ghrelin expression in
PL, in comparison to NP (4.47 fold decrease; P < 0.05),
and in comparison to PNL myometrium (4.65-fold
decrease: P < 0.05) (Figure 1). The corresponding densi-
tometric data is presented in Table 3. Total GHS-R1,
GHS-R1a, GHS-R1b, GOAT and PC1/3 mRNA expres-
sion was detected; however there was no significant
change in expression of these genes in the myometrium
in any of the 3 conditions, NP, PNL or PL (data not
shown).
Westerns-tissue
Ghrelin
Ghrelin expression was observed in the human myome-
trial tissue (Figures 2 and 3) and in HeLa cells, which were
used as a positive control (Figure 2). Protein bands of the
expected sizes for prepro-ghrelin (approximately 18 kDa),
pro-ghrelin (13 kDa) and mature ghrelin (5-6 kDa) pro-
tein were visualised by western blotting in the samples.
Two ghrelin antibodies were used for these tissue west-
erns, rabbit (sc50297) (Figure 2) and goat (sc10368)
(Santa Cruz, USA) (Figure 3). All 3 ghrelin isoforms, the
prepro-, the pro- and the mature ghrelin were visible on
the western blots however, the goat antibody had diffi-
culty hybridising to the mature human ghrelin isoform
(Figure 3). There was a significant decrease of at least 75%
(P < 0.05) in expression of the prepro- form in the PL
samples in comparison to the non-pregnant state, using
both antibodies (Figures 2(i) and 3(i)). An increase (quan-
tified by densitometric analysis to be significant, using
the goat antibody) was evident in pro-ghrelin protein lev-
els at labour, compared to non-pregnant tissue (P < 0.05)
(Figure 3(ii)). The corresponding densitometric data is
presented in Table 3.
GHS-R1
A weak band of the expected size of approximately 44
kDa was observed in the human myometrial tissue and
also in the positive control HeLa cell lysate using an anti-
body to the ghrelin receptor (Figure 4). There was a
decrease in the expression of GHS-R1 in the PL versus
those of the PNL and the NP protein samples, with a sig-
nificant decrease of 62% (P = 0.015) in the PNL compared
to the PL samples (Figure 4 and Table 3).
GOAT
GOAT protein expression was observed in the tissue
samples and in the HeLa cells (Figure 5a and 5b). A weak
band of 40-45 kDa was observed, which is slightly lower
than the expected size of 50 kDa. There was a significant
increase in GOAT protein expression at term pregnancy
compared to the non-pregnant (73%, P < 0.01) and the
labouring myometrial (137%, P < 0.001) samples (Figure
5a and Table 3).
PC1/3
PC1/3 protein expression was observed in NP, PNL and
PL tissue and in the HeLa cell lysate (Figure 6). The only
band that was observed in all cases using the Abcam
monoclonal antibody was the mature PC1/3 (with the
signal sequence cleaved), the expected size was 84 kDa
(Abcam, UK). Mature PC1/3 expression was found to be
high in the NP samples and significantly reduced, with a
2.85 (P < 0.05) and a 4.58 (P < 0.05) fold-change com-
pared to PNL and PL respectively. Furthermore, there
was a slight reduction in PC1/3 expression at labour com-
pared to term pregnancy (Figure 6 and Table 3).
Westerns-cells
Ghrelin
Ghrelin expression was monitored in the hTERT-HM
cells after 16 hour exposure to 50 ng/ml LPS, in serum-
free and phenol red-free medium. The anti-goat ghrelinO'Brien et al. Reproductive Biology and Endocrinology 2010, 8:55
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antibody was used for the cell westerns, and all ghrelin
western densitometric analyses were performed on the
prepro-ghrelin band. There was a significant decrease in
the expression of prepro-ghrelin protein of 77% (P  =
0.002) with 50 ng/ml LPS (Figure 7).
GHS-R1
GHS-R1 protein expression increased after 16 hour expo-
sure to 10-8M β-Estradiol in serum-free phenol red-free
medium, in comparison to control untreated hTERT-HM
cells (Figure 8). There was a significant 2-fold increase in
GHS-R1 protein expression after 10-8M β-estradiol treat-
ment (P = 0.0023).
GOAT and PC1/3
GOAT and PC1/3 expression was observed in the
hTERT-HM cell line and also in the HeLa cells. A repre-
sentative hTERT-HM cell western blot for each protein is
presented in Figure 9 with (i and ii) cells analysed for
GOAT expression and (iii) cell proteins hybridised to the
PC1/3 antibody.
Fluorescence microscopy
Ghrelin, GHS-R1, GOAT, PC1/3
Ghrelin protein was immunolocalised to the nucleus, the
perinucleus and in cytoplasmic vesicles (Figure 10). GHS-
R1 staining was observed in vesicle-like structures near
the nucleus, in the perinucleus, throughout the cyto-
plasm and on the cell membrane (Figure 11). GOAT
immunofluorescence staining was observed near the
nucleus and in vesicle structures near the nucleus (Figure
12). Fluorescence staining of PC1/3 protein was observed
near the nucleus and also in the in vesicles in the cyto-
plasm (Figure 13).
Discussion
This is the first report demonstrating the expression of
ghrelin, GHS-R1, GOAT and PC1/3 in human myome-
trium. There was an increase in prepro-ghrelin and
GOAT expression at pregnancy, decreasing at labour
onset, while GHS-R1 also decreased at labour. Further-
more, ghrelin processing was demonstrated at term preg-
nancy and in the non-pregnant state, in the myometrium.
Other investigators have determined that total and/or
acylated ghrelin levels in blood peak at mid-gestation and
fall to their lowest levels at the third trimester [15-18].
Ghrelin receptor GHS-R1a mRNA expression in omental
fat of pregnant women at term was found to be half that
of lean and obese non-pregnant women [30]. Reduced
ghrelin levels in third trimester maternal plasma have
been hypothesised to be a response to marked changes in
maternal energy intake [31]. However we did not deter-
mine ghrelin acylation status in the myometrium or cir-
Table 3: Summary of tissue mRNA and protein densitometry data
Non-Pregnant (NP) 
(Densitometric value ± SEM)
Pregnant not in labour (PNL) 
(Densitometric value ± SEM)
Pregnant in labour (PL) 
(Densitometric value ± SEM)
Ghrelin mRNA (Figure 1) 0.733 ± 0.171 0.761 ± 0.058 0.164 ± 0.018
Ghrelin protein (Figure 2)
Prepro-ghrelin (i) 0.655 ± 0.094 0.557 ± 0.022 0.375 ± 0.049
Pro-ghrelin (ii) 0.349 ± 0.070 0.301 ± 0.039 0.352 ± 0.075
Ghrelin (iii) 0.574 ± 0.061 0.457 ± 0.054 0.300 ± 0.091
Ghrelin protein (Figure 3)
Prepro-ghrelin (i) 1.578 ± 0.441 1.280 ± 0.092 0.521 ± 0.050
Pro-ghrelin (ii) 0.304 ± 0.068 0.677 ± 0.151 1.162 ± 0.421
GHS-R1 protein (Figure 4) 0.524 ± 0.053 0.589 ± 0.040 0.364 ± 0.054
GOAT protein (Figure 5) 0.428 ± 0.040 0.740 ± 0.073 0.311 ± 0.051
PC1/3 protein (Figure 6) 0.174 ± 0.049 0.061 ± 0.005 0.038 ± 0.004
Figure 1 Graphical representation of real-time fluorescence RT-
PCR results of β-Actin-normalised relative ghrelin mRNA quantity 
plotted against myometrial pregnancy state. NP (n = 3), PNL (n = 3), 
PL (n = 3) ± SEM (indicated by the error bars). * indicates a significance 
value of P < 0.05 between NP v PL and PNL v PL.
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culating ghrelin levels. We did investigate ghrelin, GHS-
R1, GOAT and PC1/3 expression in a small number of
women with high BMI values however, there did not
seem to be any correlation between high BMI levels and
the expression of any of these proteins in the human
myometrium at term labour or term non-labour.
Increased circulating ghrelin levels in foetuses with intra-
uterine growth restriction (IUGR) [32], increased mater-
nal plasma ghrelin levels observed in pregnancy-induced
hypertension (PIH) leading to IUGR [15] and higher
umbilical cord ghrelin plasma concentrations in small-
for-gestational-age (SGA) neonates [33] all suggest ghre-
lin acts as a "hunger signal", with a role in foetal and neo-
natal energy balance. Decreasing circulating ghrelin
levels contribute to physiological adaptation to the posi-
tive energy balance of pregnancy and reflect the nutrition
status of pregnancy while decreased expression of locally
synthesised and processed ghrelin may be involved in the
preparation of the myometrium for labour.
There are two GHS-R isoforms: GHS-R1a has 366-
amino acids with seven transmembrane regions, and
GHS-R1b, which consists of 289-amino acids and is not
activated by ghrelin. In humans GHS-R1a is present in
the pituitary, thyroid, pancreas, spleen, myocardium and
adrenal gland while GHS-R1b expression is even more
widely expressed including amongst others, the skin,
uterine fundus, ovary, testes and placenta [3,34]. Expres-
sion of mRNA for both GHS-R1a and b was identified in
the myometrium, which had not been previously
reported. GHS-R1 protein was localised to the cell sur-
face and internally in vesicles. Other investigators previ-
ously established that GHS-R1 is recycled to the cell
surface in HEK-293 cells after ghrelin binding and inter-
nalisation [35,36]. We have established that GHS-R1 pro-
Figure 2 A representative western blot of ghrelin (sc anti-rabbit 
antibody) protein expression in human myometrium. NP (n = 4), 
PNL (n = 4), PL (n = 5) and HeLa cells (H). (i) Prepro-ghrelin and (ii) pro-
ghrelin and (iii) mature ghrelin bands are indicated. The corresponding 
β-Actin (ACTB) western blot is presented underneath each blot. Molec-
ular weights are indicated in kDa. Quantitative densitometric analysis 
of each ghrelin isoform is presented below the relevant blot(s) (i-iii), 
with β-Actin normalised densitometric units for each protein plotted 
against pregnancy state ± SEM (indicated with error bars). * indicates a 
significance value of P < 0.05. Significance values indicated are com-
pared to NP tissue expression.
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Figure 3 A representative western blot of ghrelin (sc anti-goat 
antibody) protein expression in human myometrium. NP (n = 4), 
PNL (n = 4) and PL (n = 5) (i) prepro-ghrelin and (ii) pro-ghrelin and (iii) 
mature ghrelin bands are indicated. The corresponding β-Actin (ACTB) 
western blot is presented underneath each blot. Molecular weights are 
indicated in kDa. Quantitative densitometric analysis of each ghrelin 
isoform is presented below the relevant blot(s) (i-ii), with β-Actin-nor-
malised densitometric units for each protein plotted against pregnan-
cy state ± SEM (indicated with error bars). * indicates a significance 
value of P < 0.05. Significance values indicated are compared to NP tis-
sue expression.
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tein expression increased in β-Estradiol-treated estrogen
receptor-positive myometrial smooth muscle cells. Ghre-
lin expression was also regulated by estrogen in rat stom-
ach [37], while β-Estradiol significantly stimulated the
transfected human GHS-R promoter in rat pituitary cells
with estrogen-responsive elements identified in the pro-
moter region [38]. Estradiol-benzoate treatment of nor-
mal female or male rats up-regulated the expression of
hypothalamic GHS-R1 [39]. Therefore, it is postulated
that β-Estradiol increases the sensitivity of the myome-
Figure 4 A representative Western blot of GHS-R1 protein ex-
pression in human myometrial tissue samples. PL (n = 4), PNL (n = 
4) and NP (n = 5), and HeLa cells (H). The corresponding ACTB protein 
expression is presented underneath. Molecular weights are indicated 
in kDa. Quantitative densitometric analysis of the western blot is pre-
sented, with β-Actin-normalised densitometric units for GHS-R1 plot-
ted against pregnancy state ± SEM (indicated with error bars). * 
indicates a significance value of P < 0.05.
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Figure 5 Representative Western blots of GOAT protein expres-
sion in human myometrium. (a) PL (n = 5), PNL (n = 4), NP (n = 5), (b) 
HeLa cells (H) (n = 1) and myometrial PL (n = 3). The corresponding 
ACTB western blots are presented underneath each western blot. Mo-
lecular weights (M) are indicated in kDa. Quantitative densitometric 
analysis of each protein band indicated a(i-iii) is presented, with β-Ac-
tin-normalised densitometric units for GOAT plotted against pregnan-
cy state ± SEM (indicated with error bars). ** indicates a significance 
value of P < 0.01, *** indicates a significance value of P < 0.001.
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Figure 6 A representative Western blot of PC1/3 protein expres-
sion in human myometrium. NP (n = 4), PNL (n = 4), PL (n = 5) and 
HeLa cells (H). The corresponding ACTB western blots are presented 
underneath. Molecular weights (M) are indicated in kDa. Quantitative 
densitometric analysis of the western blot is presented, with β-Actin-
normalised densitometric units for PC1/3 plotted against pregnancy 
state ± SEM (indicated with error bars). * indicates a significance value 
of P < 0.05, compared to the NP tissue.
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Figure 7 Representative Western blot of prepro-ghrelin protein 
expression in LPS (50 ng/ml) treated hTERT-HM cells compared to 
control (C) untreated cells. The corresponding ACTB western blot is 
presented underneath the western blot. Molecular weights are indi-
cated in kDa. Quantitative densitometric analysis of this western blot is 
presented, with β-Actin-normalised densitometric units for prepro-
ghrelin plotted against treatment ± SEM (indicated with error bars). * 
indicates a significance value of P < 0.05, ** indicates a significance val-
ue of P < 0.01.
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trium to ghrelin, through increased GHS-R1 expression,
thus contributing to the maintenance of uterine relax-
ation during pregnancy.
Murine GOAT has been described in the stomach,
small intestine and colon tissues while human GOAT
mRNA is expressed in the stomach, intestine, pancreas
and chrondrocytes [8,9,40]. This is the first report of
GOAT expression in the uterus, where it appeared to loc-
alise in the myometrial smooth muscle cells. There was
increased myometrial GOAT expression observed at
term pregnancy and a similar pattern of GOAT protein
expression to pro-ghrelin mRNA and protein at term
compared to labour was observed, suggesting GOAT
activation and possible ghrelin acylation during preg-
nancy. Interestingly, other investigators have found that
murine stomach GOAT mRNA correlated with circulat-
ing acylated ghrelin levels [41]. Yang et al. established
that GOAT activity was inhibited by octanoylated ghrelin
pentapeptides in GOAT-transfected insect cells, suggest-
ing negative feedback regulation of acyl-ghrelin produc-
tion [42], while in pituitary cells acylated ghrelin
regulated its own production by increasing expression of
GOAT mRNA [41]. However, more investigation is
required to ascertain the mechanisms of GOAT regula-
tion in the myometrium and consequently the impact on
myometrial ghrelin processing. From these results we can
deduce that it is possible that myometrial ghrelin may be
octanoylated by GOAT in this tissue.
In addition to endocrine and neuroendocrine cells,
PC1/3 expression has been reported in rat spleen mac-
rophages and lymphocytes [43] however, this is the first
report of PC1/3 expression in the uterus, and also its sub-
sequent activation. This endoprotease is responsible for
the conversion of pro-ghrelin to ghrelin in vitro and in
vivo [11] and it has also been demonstrated that produc-
tion of n-octanoyl modified ghrelin in cultured cells
requires PC1/3, GOAT and n-octanoic acid [44]. Other
investigators have demonstrated ghrelin and PC1/3 pro-
Figure 8 Representative Western blot of GHS-R1 protein expres-
sion of β-Estradiol 10-8M (BE) treated hTERT-HM cells compared 
to control (C) untreated cells. The corresponding ACTB western blot 
is presented underneath the western blot. Molecular weights are indi-
cated in kDa. Quantitative densitometric analysis of this western blot is 
presented, with β-Actin-normalised densitometric units for prepro-
ghrelin plotted against treatment ± SEM (indicated with error bars). ** 
indicates a significance value of P < 0.01.
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Figure 9 Representative Western blots of (i and ii) GOAT protein 
expression (iii) PC1/3 expression in hTERT-HM cells and in HeLa 
cells (H). The corresponding ACTB western blot is presented under-
neath. Molecular weights are indicated in kDa.
(ii) (i)
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Figure 10 Representative immunofluorescence images of ghre-
lin localisation in human myometrial smooth muscle cells 
(hTERT-HM). The FITC negative secondary antibody control is present-
ed (iii) and scale bars are included.
(i) (ii) (iii)
Figure 11 Representative immunofluorescence images of GHS-
R1 localisation in human myometrial smooth muscle cells 
(hTERT-HM). The FITC negative secondary antibody control is present-
ed (iv) and scale bars are included.
(i) (ii) (iii) (iv)O'Brien et al. Reproductive Biology and Endocrinology 2010, 8:55
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tein co-localisation in the mouse stomach [11]. There was
increased PC1/3 protein expression in the myometrial
samples acquired at hysterectomy due to premenopausal
menorrhagia, compared to the pregnant myometrial
samples. Menorrhagia results in the disruption of normal
hormonal uterine regulation and thus increased PC1/3
protein may be responsible for the irregular pro-hormone
processing evident in this condition. Additional examina-
tion of the involvement of PC1/3 in non-pregnancy
related uterine abnormalities is therefore warranted. The
presence of active PC1/3 and mature ghrelin strongly
indicates a role for PC1/3 in the proteolytic cleavage of
pro-ghrelin in the myometrium. However, further inves-
tigation is necessary into this and its' own activation in
the myometrium. Subsequent analysis may also reveal
information relating to the processing of other pro-hor-
mones by PC1/3 in the uterus.
Parturition at term is an inflammatory process and
intra-amniotic infection/inflammation is causally linked
to preterm parturition [45]. Systemic administration of
bacterial products to pregnant animals results in preterm
delivery [46]. We have demonstrated that LPS adminis-
tration decreased myometrial smooth muscle cell ghrelin
protein. Interestingly, the bacterial polysaccharide LPS
decreased plasma ghrelin protein levels from 3 to 12 hrs
after administration in rats [47,48], and in healthy men
induced an initial increase but rapidly decreased 5 hours
after treatment [49]. Ghrelin itself exerts potent inhibi-
tory effects on proinflammatory mediators via its actions
on T cells, monocytes and endothelial cells [50-52]. In
human endothelial cells it inhibits NF-κB activation in
vitro and endotoxin-induced cytokine production in vivo
[52]. Ghrelin inhibits the expression of Il-1β, IL-6 and
TNF-α via GHS-R in human T cells while it's knockdown
activates IκB in these cells, suggesting ghrelin plays a role
in regulation of NF-κB activation [53,54]. This is signifi-
cant given that NF-κB is a key transcription factor impor-
tant in the regulation of inflammation, which plays a
central role at labour [55]. The 5' upstream region from
the start codon of the ghrelin gene contains 2 binding
sites for NF-κB suggesting a possible feedback loop.
Interestingly, the PC1/3 gene also contains two 2 putative
NF-κB binding sites. As ghrelin has anti-inflammatory
properties, decreasing ghrelin levels would enhance the
overall inflammatory pathway occurring at labour. How-
ever, further work is necessary to determine if ghrelin is
involved in NF-κB modulation and vice versa, in human
myometrium.
Conclusions
All the necessary machinery to produce active ghrelin is
present in the myometrium, suggesting ghrelin may have
an autocrine or paracrine effect in this tissue. Differential
ghrelin gene expression at term pregnancy, the presence
of ghrelin-processing enzymes and the in vitro contractil-
ity data indicates that it may play a role in the mainte-
nance of uterine relaxation during pregnancy, and that at
labour this inhibitory effect on myometrial contractility is
down-regulated. Reduced local myometrial ghrelin pro-
duction therefore may be involved in the preparation of
the uterus for labour.
Furthermore, the regulation of ghrelin expression by
significant modulators of myometrial contractility, β-
Figure 12 Representative immunofluorescence images of GOAT 
localisation in human myometrial smooth muscle cells (hTERT-
HM). The FITC negative secondary antibody control is presented (ii) 
and a scale bar is included.
(i) (ii)
Figure 13 Representative immunofluorescence images of PC1/3 
localisation in human myometrial smooth muscle cells (hTERT-
HM). The FITC negative secondary antibody control is presented (iii).
(i) (ii) (iii)O'Brien et al. Reproductive Biology and Endocrinology 2010, 8:55
http://www.rbej.com/content/8/1/55
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Estradiol and bacterial lipopolysaccharide, represents a
novel concept in terms of control of myometrial quie-
science or activity during pregnancy, and at the time of
labour. Finally, it is possible that pharmacological modu-
lation of the ghrelin pathway in uterine smooth muscle
may have future therapeutic potential.
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